Aureka Biotechnologies' AI Model Wins Global Blinded Antibody Design Competition

Aureka Biotechnologies' in-house antibody design model, AuraIDE, has won the first international AI antibody design competition, AIntibody, with results formally published in Nature Biotechnology. The AI-designed antibody achieved a 2,000-fold improvement in affinity over the parental antibody, demonstrating a significant breakthrough in generative AI for protein design and drug discovery.